Mono Pharmacare Share Price
Start SIP in Mono Pharmacare
Start SIPMono Pharmacare Performance
Day Range
- Low 33
- High 35
52 Week Range
- Low 31
- High 75
- Open Price35
- Previous Close35
- Volume44000
Mono Pharmacare Investment Rating
-
Master Rating:
-
Mono Pharmacare Ltd has an operating revenue of Rs. 246.07 Cr. on a trailing 12-month basis. An annual revenue growth of 109% is outstanding, Pre-tax margin of 3% needs improvement, ROE of 8% is fair but needs improvement. The company has a debt to equity of 61%, which is bit higher. The stock from a technical standpoint is trading below to its key moving averages. It needs to take out these levels and stay above it to make any meaningful move. From an O'Neil Methodology perspective, the stock has an EPS Rank of 91 which is a GREAT score indicating consistency in earnings, a RS Rating of 7 which is POOR indicating the underperformance as compared to other stocks, Buyer Demand at A- which is evident from recent demand for the stock, Group Rank of 40 indicates it belongs to a strong industry group of Medical-Whlsle Drg/Suppl and a Master Score of D is close to being the worst. Overall, the stock is lagging behind in some of the technical parameters, but great earnings make it a stock to examine in more detail.
EPS Strength
Price Strength
Buyer Demand
Group Rank
| Indicator | Mar 2024 | Mar 2023 |
|---|---|---|
| Total Revenue Annual Cr | 72 | 46 |
| Operating Expenses Annual Cr | 68 | 43 |
| Operating Profit Annual in Cr | 2 | 2 |
| Depreciation Cr | 0 | 0 |
| Interest Annual Cr | 1 | 1 |
| Tax Annual Cr | 0 | 0 |
| Net Profit Annual Cr | 2 | 1 |
Mono Pharmacare Technicals
EMA & SMA
- Bullish Moving Average
- ___
- 0
- Bearish Moving Average
- ___
- 16
- 20 Day
- ₹37.15
- 50 Day
- ₹39.17
- 100 Day
- ₹41.71
- 200 Day
- ₹45.32
- 20 Day
- ₹37.40
- 50 Day
- ₹38.66
- 100 Day
- ₹43.07
- 200 Day
- ₹46.41
Mono Pharmacare Resistance and Support
| Resistance | |
|---|---|
| First Resistance | 34.12 |
| Second Resistance | 34.93 |
| Third Resistance | 35.37 |
| RSI | 33.45 |
| MFI | 49.49 |
| MACD Single Line | -0.75 |
| MACD | -1.14 |
| Support | |
|---|---|
| First Support | 32.87 |
| Second Support | 32.43 |
| Third Supoort | 31.62 |
Mono Pharmacare Delivery and Volume
| Period | NSE + BSE Volume Avg | NSE + BSE Delivery Volume Avg | NSE + BSE Delivery Volume % |
|---|---|---|---|
| Day | 8,000 | 800,000 | 100 |
| Week | 6,000 | 600,000 | 100 |
| 1 Month | |||
| 6 Month | 12,839 | 1,038,652 | 80.9 |
Mono Pharmacare Result Highlights
Mono Pharmacare Synopsis
NSE-Medical-Whlsle Drg/Suppl
Mono Pharmacare belongs to the Industry of Pharmaceuticals. Company’s Total Operating Revenue is Rs. 45.40 Cr. and Equity Capital is Rs. 12.37 Cr. for the Year ended 31/03/2023. Mono Pharmacare Ltd. is a Public Limited Listed company incorporated on 06/05/1994 and has its registered office in the State of Gujarat, India. Company’s Corporate Identification Number(CIN) is U24304GJ2022PLC136193 and registration number is 136193.| Market Cap | 62 |
| Sales | 71 |
| Shares in Float | 0.76 |
| No of funds | |
| Yield |
| Book Value | 2.2 |
| U/D Vol ratio | 0.9 |
| LTDebt / Equity | 15 |
| Alpha | |
| Beta | 1.01 |
Mono Pharmacare Shareholding Pattern
| Owner Name | Mar-24 | Dec-23 | Sep-23 |
|---|---|---|---|
| Promoters | 56.72% | 56.72% | 56.72% |
| Individual Investors | 36.69% | 37.2% | 38.13% |
| Others | 6.59% | 6.08% | 5.15% |
Mono Pharmacare Management
| Name | Designation |
|---|---|
| Mr. Panilam Lakhatariya | Chairman & Managing Director |
| Mrs. Supal Lakhatariya | Non Executive Director |
| Mr. Archit Shah | Executive Director |
| Mr. Mitul Sapara | Non Executive Director |
| Mr. Chinta Trivedi | Ind. Non-Executive Director |
| Mr. Gaurang Vora | Ind. Non-Executive Director |
Mono Pharmacare Forecast
Price Estimates
Mono Pharmacare Corporate Action
| Date | Purpose | Remarks |
|---|---|---|
| 2024-08-06 | Others | To take note of resignation of Mrs. Pooja Seth as Company Secretary and Compliance Officer of the Company and other business matters. |
| 2024-04-29 | Others | To consider other business matters |
Mono Pharmacare FAQs
What is Share Price of Mono Pharmacare ?
Mono Pharmacare share price is ₹33 As on 20 September, 2024 | 00:08
What is the Market Cap of Mono Pharmacare ?
The Market Cap of Mono Pharmacare is ₹58.8 Cr As on 20 September, 2024 | 00:08
What is the P/E ratio of Mono Pharmacare ?
The P/E ratio of Mono Pharmacare is As on 20 September, 2024 | 00:08
What is the PB ratio of Mono Pharmacare ?
The PB ratio of Mono Pharmacare is 2.1 As on 20 September, 2024 | 00:08